oasis trial semaglutide 1 Efficacy of Oral Semaglutide: Overview of the PIONEER Clinical Trial Program and Implications for Managed Care OASIS 2 Trial: Oral Semaglutide
Description
Ozempic is a weekly injection that mimics a gut hormone to curb appetite, slow gastric emptying, and promote significant weight loss
Furthermore, the addition of exenatide to pioglitazone (already known for its benefits on NAFLD) was associated with a greater reduction in hepatic fat content compared to pioglitazone monotherapy [71]
It is FDA-approved for weight management
Most Aetna commercial plans cover it with prior authorization
Several large studies have shown positive results for people with kidney disease: The LEADER Trial: A medication called liraglutide lowered the risk of kidney problems by 22%4
